UpdatesPlus - Immunology

Description

Source URL:

https://news.abbvie.com/2026-04-27-AbbVie-Submits-Regulatory-Application-to-FDA-for-SKYRIZI-R-risankizumab-rzaa-Subcutaneous-Induction-for-Adults-with-Moderately-to-Severely-Active-Crohns-Disease